What “Lasting” Means With Nose Filler, and How to Plan Touch Ups Conservatively
If you are considering non-surgical rhinoplasty (often called liquid rhinoplasty), the question you are really asking is practical: will your profile still look refined months from now, and how do you plan maintenance without overdoing it?
In the published medical literature, “how long it lasts” is not a single predictable number. A 2023 literature review concluded that establishing longevity with certainty is extremely complex, with discordant durations reported across the studies it reviewed.
For clients across Toronto, Vaughan, and the GTA, the most useful way to think about longevity is to separate early shape support from gradual resorption, then plan a follow up reassessment based on how your own nose settles and heals.
First, a quick Canada context for “Nose filler”
In Canada, dermal fillers are regulated as medical devices by Health Canada. Health Canada’s dermal filler guidance emphasizes that indications are expected to specify the injection site and the depth of injection, and that labelling is expected to state the expected duration of the treatment effect (where applicable).
Non-surgical rhinoplasty (injecting filler into the nose) is commonly performed in practice, but the sources retrieved here do not provide a Health Canada authorized indication specifically for nasal shaping or augmentation. For that reason, it is best understood as an off label anatomical site use unless the specific product’s Canadian Instructions for Use explicitly includes the nose.
If you are deciding whether this treatment fits your goals, this context matters because it puts extra weight on a careful, anatomy first assessment and truly informed consent.
What “Lasting” means in non-surgical rhinoplasty
Longevity in non-surgical rhinoplasty is usually experienced as two phases. Thinking in phases helps you plan follow up more wisely than chasing a fixed calendar date.
Phase 1: early shape support
Right after filler is placed, the visible change comes from the gel’s immediate shape support and the way it supports tissue. This is the phase most people picture when they think about “liquid rhinoplasty.”
A 2024 systematic review of hyaluronic acid use in non-surgical rhinoplasty reviewed published studies that reported different injected subunits, with the tip most commonly injected, followed by the columella. This matters for “lasting” because the location and technique behind the shape change can influence how stable the result looks over time.
Phase 2: gradual resorption
Over time, the effect can fade as the filler gradually resorbs, and the rate is not identical across people or across published studies. The 2023 literature review explicitly concluded that establishing longevity with certainty is extremely complex, noting discordant durations and calling for standardized imaging and photography studies.
In that review’s results, from 228 extracted articles, 16 studies were selected. The review reports that according to six authors, the duration of treatment is between 8 and 12 months. It also reports that for other authors the results seem to last longer than this period, and the longest time interval reported was 8 years.
What can influence fading or a change in the look
Clients often describe longevity as, “I still feel it is there, but the refinement looks softer,” or, “I can see my profile shifting back.” Some of that is resorption, and some is how the result reads on your face as healing settles and you get used to the change.
Placement and technique are part of the longevity story
The 2024 systematic review supports the idea that non-surgical rhinoplasty is not one uniform technique. Across published studies, injected areas vary, and so do the exact shape goals reported, such as treating hump deformities. In practical terms, “how long it lasts” is closely tied to what was changed and where.
Your history with filler should be part of the plan
Health Canada’s dermal filler guidance includes warnings that are expected to appear in Instructions for Use, including “Injection of the device where there is a possibility of interaction with a previously injected dermal filler.” Even though this point is framed as a labelling expectation, it becomes a real world planning issue in the nose.
The non obvious decision point is that maintenance is not only about adding more for longevity. It also includes deciding whether a touch up is appropriate at all based on what has been injected before, where it sits, and how your nose has responded.
Planning a touch up timeline with conservative reassessment
The most evidence aligned way to approach maintenance is to plan for reassessment rather than assuming everyone will follow the same yearly schedule. The published longevity ranges are wide, and the 2023 review is clear that certainty is difficult.
What a good follow up visit is for
A follow up is the moment to look closely at how the nose has settled and how the shape reads from different angles, then decide whether any refinement makes sense. The 2024 systematic review characterizes hyaluronic acid non-surgical rhinoplasty as having minimal side effects and a short recovery period, with high patient satisfaction reported across included studies. It also reports that among 3,928 patients reviewed across 23 full text articles, eight developed major complications. Those two realities belong in the same conversation, because they support a conservative stepwise approach.
What you should be told to watch for urgently
When you choose a clinic for any dermal filler, you should leave with clear instructions on warning signs that need immediate medical attention. Health Canada’s Health Product InfoWatch (August 2016) emphasizes serious harms can occur from inadvertent vascular injection, including permanent vision impairment, blindness, stroke, and necrosis.
The same InfoWatch lists symptoms that warrant immediate attention after filler injection: unusual pain, vision changes, blanching of the skin, and any neurological changes associated with a stroke, including sudden difficulty speaking, numbness or weakness in face, arms, or legs, difficulty walking, face drooping, severe headache, dizziness, or confusion.
Who should pause and have a deeper medical discussion first
Non-surgical rhinoplasty is elective. A careful injector should screen for patient specific factors that belong in dermal filler contraindications and warnings, and they should be willing to postpone treatment when safety or expectations are not aligned.
Contraindications and precautions Health Canada expects manufacturers to list
Health Canada’s dermal filler guidance outlines what should appear in contraindications and warnings in product labelling. Items it lists include lactating and pregnant women, children, patients with hypersensitivity to any of the device materials, patients with bleeding disorders, patients susceptible to keloid formation, hyperpigmentation or hypertrophic scarring, and tissue with infection or inflammation. It also includes incompatible medical and psychological conditions of the patient, including unrealistic expectations.
It also states that warnings and precautions applicable to all dermal fillers that should be listed in Instructions for Use include the risks of potential complications associated with intravascular injection, avoiding injection into blood vessels, injection into patients with a history of previous herpetic eruption may cause reactivation of the herpes, interaction with a previously injected dermal filler, and that the device should only be injected by a qualified medical practitioner who has sufficient training with the use of the device. The guidance also states the patient should be given sufficient information regarding potential adverse events and complications to make an informed decision concerning treatment.
Questions to bring to a consultation
If your main goal is a refined profile without surgery, the best consultation questions are the ones that connect your anatomy, your history, and your follow up plan.
- “Based on my nose shape, what change are you planning, and which subunit are you treating?”
- “How do you define ‘lasting’ for my result: what should I expect to remain, and what tends to soften first?”
- “How does my history of prior filler affect both safety and predictability for touch ups?”
- “What urgent symptoms do you want me to treat as an emergency, and how do I reach care quickly if they happen?”
- “What does follow up look like for you, and how do you decide whether a touch up is appropriate?”
How Ontario accountability affects touch ups
A touch up is still a treatment episode, and it should be treated with the same seriousness as the first appointment. The College of Nurses of Ontario (CNO) notes that aesthetic services may include controlled acts, and gives examples including dermal fillers.
The CNO also states that practice standard changes were approved September 24, 2026 and will take effect Monday, March 1, 2027. Those changes include expectations that nurses providing aesthetic services will use client specific orders instead of directives for aesthetic services involving prescription drugs or controlled acts, and that when delegating a controlled act to someone without authority, nurses must be onsite for the entirety of the procedure the nurse delegated. For you as a client, this translates into a clear expectation of structured assessment, documentation, and accountable follow up every time.
Where JUVEDERM fits into this conversation
You will often hear brand names mentioned online, and it is reasonable to wonder what is actually licensed in Canada. Health Canada’s Medical Devices Active Licence Listing (MDALL) shows an active Class 3 Device Family licence “JUVEDERM” (Licence No. 64039) with device names “JUVEDERM ULTRA PLUS XC” and “JUVEDERM ULTRA XC.” MDALL confirms licensing status and identifiers, but it does not provide the full Canadian Instructions for Use, contraindications, or authorized indications within the record view retrieved here.
In the research literature, the 2024 systematic review reports that for non-surgical rhinoplasty, Juvéderm ultra was the most commonly used hyaluronic acid filler in the included studies. Published usage does not equal a Health Canada authorized nasal indication, which is why a consultation should focus on the specific product’s Canadian Instructions for Use and on your individualized risk discussion.
If your question is “non-surgical rhinoplasty how long does it last,” the most honest answer is that published reports range widely, and planning is safest when it is built around reassessment. Longevity can be discussed, but it is never a calendar guarantee.
If you want a refined profile without surgery and a conservative plan for maintenance, start with a personalized assessment for non-surgical rhinoplasty with filler, including your treatment history, your follow up approach, and the exact warning signs you should act on right away.
- Beneduce n, et al. “The longevity of the nonsurgical rhinoplasty: a literature review” (J stomatol oral maxillofac surg. 2023 Feb;124(1S):101319)
- Health product infoWatch – August 2016: “Adverse incidents with injectable dermal fillers – facial vascular compromise: update”
- Mortada h, et al. “The use of hyaluronic acid in non-surgical rhinoplasty: a systematic review of complications, clinical, and patient-reported outcomes” (Aesthetic plast surg. 2024 Jan;48(2):194-209)
- Guidance document: preparation of premarket medical device licence and licence amendment applications for dermal fillers (Date adopted: 2016/11/24; effective date: 2017/01/16)
- College of Nurses of Ontario (CNO): aesthetic services (includes effective date March 1, 2027; references July 6, 2026 guideline)